Committee Opinion
Number 562, May 2013
(Replaces No. 355, December 2006, Reaffirmed 2016)

Committee on Adolescent Health Care
This document reflects emerging clinical and scientific advances as of the date issued and is subject to change. The information should not be construed as dictating an exclusive course of treatment or procedure to be followed.
PDF Format

Müllerian Agenesis: Diagnosis, Management, and Treatment

ABSTRACT: Müllerian agenesis occurs in 1 out of every 4,000–10,000 females. The most common presentation of müllerian agenesis is congenital absence of the vagina, uterus, or both, which also is referred to as müllerian aplasia, Mayer–Rokitansky–Küster–Hauser syndrome, or vaginal agenesis. Satisfactory vaginal creation usually can be managed nonsurgically with successive vaginal dilation; however, there are a variety of surgical options for creation of a neovagina. Regardless of the treatment option selected, patients should be thoroughly counseled and prepared psychologically before the initiation of any treatment. Evaluation for associated congenital renal anomalies or other anomalies is also important. Although exact gynecologic screening recommendations are evolving, all women with a neovagina should undergo routine gynecologic care; however, vaginal cytologic screening is not indicated.

Müllerian agenesis also is referred to as müllerian aplasia, Mayer–Rokitansky–Küster–Hauser syndrome, or vaginal agenesis. Given an incidence of 1 per 4,000–10,000 females, most general gynecologists will only encounter müllerian agenesis once or twice during their careers (1). Müllerian agenesis is caused by embryologic growth failure of the müllerian duct, with resultant agenesis or underdevelopment of the vagina, uterus, or both. The vaginal canal is absent or markedly shortened. A single midline uterine remnant may be present or uterine horns (with or without an endometrial cavity) can exist. The ovaries, given their separate embryologic source, are normal in structure and function.

Differential Diagnosis

Patients with müllerian agenesis typically present with primary amenorrhea in adolescence with normal growth and development. After gonadal dysgenesis, müllerian agenesis is the second most common cause of primary amenorrhea (2). On physical examination, patients with müllerian agenesis have normal height, secondary sexual characteristics, body hair, and external genitalia. Furthermore, a vagina is either absent or present as a short blind-ended structure without a cervix at the vaginal apex. Patients with müllerian agenesis have a normal 46,XX karyotype and a normal hormonal profile.

The differential diagnosis of müllerian agenesis includes congenital absence of the vagina (with or without uterine structures), a low transverse vaginal septum, an imperforate hymen, as well as 46,XY disorders of sex development, including androgen insensitivity and 17α-hydroxylase deficiency.

In contrast to most patients with müllerian aplasia, the patient with an imperforate hymen will not have the typical fringe of hymenal tissue. The patient with a low transverse vaginal septum will have a normal hymen with more proximal obstruction of the vaginal canal. In addition to presenting with primary amenorrhea, the latter two conditions occur with symptoms of cyclic abdominal or pelvic pain and a pelvic mass due to the obstructed outflow tract and associated hematocolpos. Pelvic imaging may be helpful to distinguish this disorder.

In cases of androgen insensitivity, the gonads are testes, which produce normal androgens. The lack of functional androgen tissue receptors results in sparse or no pubic and axillary hair. Patients with androgen insensitivity typically have normal breast development because of the peripheral conversion of the circulating androgens to estrogens. They may have a small lower vagina or a normal vaginal length; however, no uterus or cervix is present because of the in utero production of müllerian inhibiting substance by the testes. In pubertal females, the diagnosis between androgen insensitivity and müllerian agenesis can be made by assessing serum testosterone levels, followed by karyotype analysis, if a level in the pubertal male range is indicated in the results. Determining karyotype is helpful in prepubertal children who do not yet have postpubertal sex steroid production.

In cases of 17α-hydroxylase deficiency, individuals will have phenotypically normal female external genitalia, a blind short vaginal pouch, no uterus or fallopian tubes, and dysgenetic intra-abdominal testes. Affected males usually are raised as females, and the underlying disorder is recognized when the patient is evaluated for lack of pubertal development (3, 4). Because of the risk of neoplasm, it is important that gonadectomy be performed in patients with 46,XY disorders of sex development. The individual risk of neoplasm is estimated based on the molecular diagnosis and age (5).

Evaluation of the Patient With Müllerian Agenesis

Conventional transabdominal, translabial, or transrectal ultrasonography; three-dimensional ultrasonography; and magnetic resonance imaging can be used to evaluate the müllerian structures and are helpful in definitively characterizing anatomy. Most patients with müllerian agenesis have small rudimentary müllerian bulbs without any endometrial activity. In 2–7% of patients with müllerian agenesis, active endometrium is found in these uterine structures (1). These patients will present with cyclic or chronic abdominal pain. Magnetic resonance imaging has been suggested to assess the reproductive anatomy, although it rarely is needed in the initial evaluation unless ultrasound evaluation for the presence of functional endometrium in a müllerian structure is equivocal (6). Although laparoscopy is not necessary to diagnose müllerian agenesis, it may be useful in the treatment of patients with functional rudimentary uterine horns (7). When obstructed hemi-uteri are identified (uterine horns with the presence of active endometrium without an associated cervix and upper vagina), then laparoscopic removal of the unilateral or bilateral obstructed uterine structures should be performed (8, 9). Endometriosis can develop from retrograde menstruation from the obstructed uterine horn, which presents as dysmenorrhea and pelvic pain. In most cases, surgical excision of the uterine horn results in resolution of the endometriosis (10).

Evaluation for associated congenital, renal, or other anomalies is essential because up to 53% of patients with müllerian agenesis have concomitant congenital malformations, especially of the abdominal wall, urinary tract, and skeleton (11). Ultrasonography can be used to screen for the more common findings of renal agenesis or a pelvic kidney. Scoliosis is the most common skeletal abnormality associated with müllerian agenesis (11). It also should be noted that there is an increased, but small, rate of hearing impairment in patients with müllerian agenesis (11). A variety of uterine anomalies, including müllerian agenesis, can be seen in association with other anomalies and syndromes, such as VATER/VACTERL and anorectal malformations (12).

Management of Patients With Müllerian Agenesis

Management of patients with müllerian agenesis includes psychosocial counseling to address the functional and emotional effects of genital anomalies as well as correction of the anatomical defect. After the diagnosis of müllerian agenesis, the adolescent should be offered counseling to emphasize that healthy sexual relationships are possible. Future fertility options should be addressed with adolescents and their parents or guardians. Discussion of assisted reproductive techniques and use of a gestational carrier (surrogate) is appropriate. Female offspring of women conceived by assisted reproductive technology typically have normal reproductive tracts; although familial aggregates of müllerian agenesis have been documented, the mode of inheritance is unclear (13, 14). This information allows adolescents and young women to understand their reproductive potential for becoming a biologic parent and may help them deal with the diagnosis and its implications. The best predictor of good emotional outcome after diagnosis and vaginal creation is a good relationship between the patient and her parent(s) or guardian(s) and the ability to share feelings with family and friends (8). Contact with a support group of young women with the same diagnosis may be helpful (see Resources) (7). Referral to a mental health professional for ongoing support is worthwhile for some patients. Patients should be given a brief, written medical summary of their condition, including a summary of potential concomitant malformations. This information may be useful if the patient requires urgent medical care or emergency surgery from a health care provider unfamiliar with müllerian agenesis.

Nonsurgical Creation of a Neovagina

Timing for nonsurgical or surgical creation of a neovagina is elective; however, it is best planned when the patient is emotionally mature and expresses the desire for correction. Nonsurgical creation of the vagina is the appropriate first-line approach in most patients.

Successful self-dilation requires patients to manually place successive dilators on the vaginal dimple for 30 minutes to 2 hours per day. Alternatively, a bicycle seat stool can provide perineal pressure while allowing the patient to participate in other activities (15). Many young women find that sitting on the bicycle seat stool is too uncomfortable or awkward, thus they may have better success using dilators while reclining. Mature, highly motivated patients who wish to avoid surgery and are aware that it will take several months to achieve their goal are likely to be successful with this technique (15, 16). In a recently reported series of patients with müllerian agenesis, 90–95% of the patients were able to achieve anatomic and functional success by vaginal dilation (17, 18). Health care providers often use peer mentors (other patients with vaginal agenesis who have successfully dilated), as support to the young woman attempting dilation. Sexually experienced patients may present with natural dilation of the vaginal dimple and occasionally require no additional dilation therapy. However, patients who successfully use dilation therapy may require continuation of dilation on an intermittent basis if they are not regularly engaging in vaginal intercourse.

Surgical Creation of a Neovagina

Surgery is an option for patients who are unsuccessful with dilators or for patients who prefer surgery after a thorough informed consent discussion with their health care providers and their respective parents or guardians, if appropriate. Surgical creation of a vagina requires ongoing postoperative dilation or vaginal intercourse to maintain adequate vaginal length and diameter.

The aim of surgery is the creation of a vaginal canal in the correct axis of adequate size and secretory capacity to allow intercourse. The timing of the surgery depends on the patient and the type of procedure planned. Surgical procedures often are performed in late adolescence or young adulthood (ages 17–21 years) when the patient is mature enough to be able to adhere to postoperative dilation. Because patient motivation is an important component of successful outcomes, it is wise to delay surgical therapy until the patient is ready to engage in vaginal intercourse.,

A number of surgical techniques can be used to create a neovagina. The approach usually is based on the experience of the operating surgeon. Regardless of the technique chosen, referrals to centers with expertise should be considered. The surgeon must be experienced with the procedure because the initial procedure is more likely to succeed than follow-up procedures. Reoperation in these cases increases the chance of operative injury to surrounding tissues and the possibility of a poor functional outcome. At present, there is no consensus in the literature regarding the best option for surgical correction to afford the best functional outcome and sexual satisfaction (19).

Historically, the most common surgical procedure used to create a neovagina has been the modified Abbe–McIndoe operation. This procedure involves the dissection of a space between the rectum and bladder, placement of a mold covered with a split-thickness skin graft into the space, and the diligent use of vaginal dilation postoperatively. Postoperative dilation is essential to prevent significant skin graft contracture; therefore, this technique is inappropriate if the patient has concerns about or objects to dilation. The dilators must be intermittently used until the woman engages in regular and frequent sexual intercourse.

Other procedures for the creation of the neovagina are the Vecchietti procedure and other laparoscopic modifications of operations previously performed by laparotomy (20). The laparoscopic Vecchietti procedure is a modification of the open technique where a neovagina is created using continuous dilation with an external traction device that is temporarily affixed to the abdominal wall (21). Davydov developed a three-stage operation, which requires dissection of the rectovesicular space with abdominal mobilization of a segment of the peritoneum, and subsequent attachment of the peritoneum to the introitus (9, 22–24). Other techniques, such as bowel graft neovagina, use of buccal mucosa, amnion, and various other allografts, are less commonly applied to women with müllerian agenesis.

General Gynecologic Care

Women who have a history of müllerian agenesis and have created a functional vagina require routine gynecologic care. Regular pelvic examinations should be performed to examine for vaginal stricture or stenosis. Sexually active women with müllerian agenesis should be aware that they are at risk of sexually transmitted diseases and, thus, should use condoms and be appropriately screened according to guidelines for women without müllerian agenesis. In addition, vaginal speculum examination and inspection should be performed to look for possible malignancies (in cases of skin graft or bowel vaginas), colitis, ulceration (in cases of bowel vaginas), or other problems. Routine vaginal cytologic testing is not recommended. Insufficient evidence is available to guide the decision for human papillomavirus vaccination of women with dilated or surgically created vaginas, although the theoretic risk of vaginal neoplasia and genital warts is present (25).


The most important steps in the effective management of müllerian agenesis are correct diagnosis of the underlying condition, evaluation for associated congenital anomalies, and psychosocial counseling before any treatment or intervention to address the functional and emotional effects of genital anomalies. Laparoscopy is seldom required to make the diagnosis but may be appropriate in the patient presenting with pelvic pain. Nonsurgical creation of the neovagina should be the first-line approach. In cases in which surgical intervention is required, referrals to centers with expertise in this area should be considered because few surgeons have extensive experience in construction of the neovagina.


The following resources are for information purposes only. Referral to these sources and web sites does not imply the endorsement of ACOG. These resources are not meant to be comprehensive. The exclusion of a source or web site does not reflect the quality of that source or web site. Please note that web sites are subject to change without notice.

MRKH Organization, Inc.
PO Box 301494, Jamaica Plain, MA 02130

Center for Young Women’s Health
333 Longwood Avenue, 5th floor
Boston, MA 02115
(617) 355-2994

Center for Young Women’s Health. MRKH: a guide for teens. Available at: Retrieved January 31, 2013.

Center for Young Women’s Health. MRKH: a guide for parents and guardians. Available at: Retrieved January 31, 2013.


  1. Evans TN, Poland ML, Boving RL. Vaginal malformations. Am J Obstet Gynecol 1981;141:910–20. [PubMed]
  2. Reindollar RH, Byrd JR, McDonough PG. Delayed sexual development: a study of 252 patients. Am J Obstet Gynecol 1981;140:371–80. [PubMed]
  3. New MI. Male pseudohermaphroditism due to 17 alpha-hydroxylase deficiency. J Clin Invest 1970;49:1930–41. [PubMed] [Full Text]
  4. Nieman LK. Uncommon causes of congenital adrenal hyperplasia. In: UpToDate, Basow, DS (Ed), UpToDate, Waltham, MA, 2013.
  5. Wunsch L, Holterhus PM, Wessel L, Hiort O. Patients with disorders of sex development (DSD) at risk of gonadal tumour development: management based on laparoscopic biopsy and molecular diagnosis. BJU Int 2012;110: E958–65. [PubMed] [Full Text]
  6. Fedele L, Dorta M, Brioschi D, Giudici MN, Candiani GB. Magnetic resonance imaging in Mayer-Rokitansky-Kuster-Hauser syndrome. Obstet Gynecol 1990;76:593–6. [PubMed] [Obstetrics & Gynecology]
  7. Laufer MR. Structural abnormalities of the female reproductive tract. In: Emans SJ, Laufer MR, editors. Emans, Laufer, Goldstein’s pediatric and adolescent gynecology. 6th ed. Philadelphia (PA): Wolters Kluwer; Lippincott Williams & Wilkins; 2012. p. 188–237.
  8. Poland ML, Evans TN. Psychologic aspects of vaginal agenesis. J Reprod Med 1985;30:340–4. [PubMed]
  9. Adamyan LV. Laparoscopic management of vaginal aplasia with or without functional noncommunicating rudimentary uterus. In: Arregui ME, Fitzgibbons RJ Jr, Katkhoudia N, McKernan JB, Reich H, editors. Principles of laparoscopic surgery: basic and advanced techniques. New York (NY): Springer-Verlag; 1995. p. 646–51.
  10. Cho MK, Kim CH, Oh ST. Endometriosis in a patient with Rokitansky-Kuster-Hauser syndrome. J Obstet Gynaecol Res 2009;35:994–6. [PubMed]
  11. Oppelt P, Renner SP, Kellermann A, Brucker S, Hauser GA, Ludwig KS, et al. Clinical aspects of Mayer-Rokitansky-Kuester-Hauser syndrome: recommendations for clinical diagnosis and staging. Hum Reprod 2006;21:792–7. [PubMed] [Full Text]
  12. Breech L. Gynecologic concerns in patients with anorectal malformations. Semin Pediatr Surg 2010;19:139–45. [PubMed]
  13. Petrozza JC, Gray MR, Davis AJ, Reindollar RH. Congenital absence of the uterus and vagina is not commonly transmitted as a dominant genetic trait: outcomes of surrogate pregnancies. Fertil Steril 1997;67:387–9. [PubMed] [Full Text]
  14. Carson SA, Simpson JL, Malinak LR, Elias S, Gerbie AB, Buttram VC Jr, et al. Heritable aspects of uterine anomalies. II. Genetic analysis of Mullerian aplasia. Fertil Steril 1983;40:86–90. [PubMed]
  15. Williams JK, Lake M, Ingram JM. The bicycle seat stool in the treatment of vaginal agenesis and stenosis. J Obstet Gynecol Neonatal Nurs 1985;14:147–50. [PubMed]
  16. Rock JA, Breech LL. Surgery for anomalies of the Mullerian ducts. In: Rock JA, Jones HW 3rd, editors. Te Linde’s operative gynecology. 10th ed. Philadelphia (PA): Lippincott Williams & Wilkins; 2008. p. 539–84.
  17. Roberts CP, Haber MJ, Rock JA. Vaginal creation for mullerian agenesis. Am J Obstet Gynecol 2001;185:1349–52; discussion 1352–3. [PubMed] [Full Text]
  18. Edmonds DK, Rose GL, Lipton MG, Quek J. Mayer-Rokitansky-Kuster-Hauser syndrome: a review of 245 consecutive cases managed by a multidisciplinary approach with vaginal dilators. Fertil Steril 2012;97:686–90. [PubMed] [Full Text]
  19. Laufer MR. Congenital absence of the vagina: in search of the perfect solution. When, and by what technique, should a vagina be created? Curr Opin Obstet Gynecol 2002; 14:441–4. [PubMed]
  20. Brucker SY, Gegusch M, Zubke W, Rall K, Gauwerky JF, Wallwiener D. Neovagina creation in vaginal agenesis: development of a new laparoscopic Vecchietti-based procedure and optimized instruments in a prospective comparative interventional study in 101 patients. Fertil Steril 2008;90:1940–52. [PubMed] [Full Text]
  21. Borruto F, Chasen ST, Chervenak FA, Fedele L. The Vecchietti procedure for surgical treatment of vaginal agenesis: comparison of laparoscopy and laparotomy. Int J Gynaecol Obstet 1999;64:153–8. [PubMed] [Full Text]
  22. Davydov SN, Zhvitiashvili OD. Formation of vagina (colpopoiesis) from peritoneum of Douglas pouch. Acta Chir Plast 1974;16:35–41. [PubMed]
  23. Adamyan LV. Therapeutic and endoscopic perspectives. In: Nichols DH, Clarke-Pearson DL, editors. Gynecologic, obstetric, and related surgery. 2nd ed. St. Louis (MO): Mosby; 2000. p. 1209–17.
  24. Allen LM, Lucco KL, Brown CM, Spitzer RF, Kives S. Psychosexual and functional outcomes after creation of a neovagina with laparoscopic Davydov in patients with vaginal agenesis. Fertil Steril 2010;94:2272–6. [PubMed] [Full Text]
  25. Frega A, Scirpa P, Sopracordevole F, Biamonti A, Bianchi P, De Sanctis L, et al. Impact of human papillomavirus infection on the neovaginal and vulval tissues of women who underwent surgical treatment for Mayer–Rokitansky–Kuster–Hauser syndrome. Fertil Steril 2011;96:969–73. [PubMed] [Full Text]

Copyright May 2013 by the American College of Obstetricians and Gynecologists, 409 12th Street, SW, PO Box 96920, Washington, DC 20090-6920. All rights reserved.

ISSN 1074-861X

Müllerian agenesis: diagnosis, management, and treatment. Committee Opinion No. 562. American College of Obstetricians and Gynecologists. Obstet Gynecol 2013;121:1134–7.

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998